Table 2.
Pre-treatment (n=191) | During Anastrozole (n=191) | |
---|---|---|
Estrone | ||
No. patients | 189 | 191 |
Missing | 2 | 0 |
Mean (SD) | 23.2 (15.64) | 1.0 (4.28) |
Median | 19.9 | 0.0 |
Range | 0.0-111.0 | 0.0-45.2 |
Estradiol | ||
N. patients | 188 | 189 |
Missing | 3 | 2 |
Mean (SD) | 5.8 (5.41) | 1.1 (7.75) |
Median | 3.9 | 0.0 |
Range | 0.0-40.3 | 0.0-97.0 |
Estrone conjugates | ||
No. patients | 189 | 190 |
Missing | 2 | 1 |
Mean (SD) | 340.5 (386.78) | 53.4 (239.15) |
Median | 226.0 | 12.1 |
Range | 7.7-3320.0 | 0.0-2990.0 |
Androstenedione | ||
No. patients | 189 | 191 |
Missing | 2 | 0 |
Mean (SD) | 515.8 (310.85) | 573.3 (303.73) |
Median | 451.0 | 486.0 |
Range | 0.0-2470.0 | 0.0-1560.0 |
Testosterone | ||
No. patients | 187 | 191 |
Missing | 4 | 0 |
Mean (SD) | 183.4 (134.53) | 183.1 (116.92) |
Median | 151.0 | 160.0 |
Range | 0.0-1120.0 | 0.0-678.0 |